EBMT 2023 Archives - Medical Conferences

Home > Haematology > EBMT 2023

Read the full Report (pdf)

European Group for Blood & Marrow Transplantation
23–26 April 2023 Paris, France

Featured articles

Letter from the Editor

Editor

Prof. Gert Ossenkoppele, Amsterdam UMC, the Netherlands

Conference

EBMT 2023

15 June, 2023 13:27

EBMT 2023 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

EBMT 2023

14 May, 2023 20:09

CAR T cells rise to the front in multiple myeloma

Expert

Dr Sergio Giralt, Memorial Sloan Kettering Cancer Center, USA

Trial

Phase 3, KarMMa-3

17 April, 2023 12:45

Online First

Acute Leukaemia

Quizartinib plus chemotherapy improves OS in patients with AML undergoing ASCT

Presented By

Prof. Radovan Vrhovac, University Hospital Centre Zagreb, Croatia

Trial

Phase 3, QuANTUM-First

Conference

EMBT 2023

14 June, 2023 20:07

Blinatumomab may improve outcomes in patients with B-cell ALL undergoing ASCT

Presented By

Dr Ayman Sayyed, University of Toronto, Canada

Conference

EBMT 2023

14 June, 2023 20:02

Is ASCT a reasonable option in patients with invasive aspergillosis?

Presented By

Prof. Olaf Penack, Charité University Hospital of Berlin, Germany

Conference

EBMT 2023

14 June, 2023 19:55

Tacrolimus versus cyclosporine A in AML

Presented By

Dr Gesine Bug, Goethe University Frankfurt, Germany

Conference

EBMT 2023

14 June, 2023 19:48

Promising novel target identified for AML

Presented By

Prof. Edmund Waller, Emory University, GA, USA

Conference

EBMT 2023

14 June, 2023 19:42

Multiple Myeloma

Ide-cel superior to standard therapies in triple-class exposed RRMM

Presented By

Dr Paula Rodríguez-Otero, Clinica Universidad de Navarra, Spain

Trial

Phase 3, KarMMa-3

Conference

EBMT 2023

15 June, 2023 16:48

ASCT or CAR T cell as first-line therapy for MM?

Presented By

Prof. Salomon Manier, Lille University Hospital, France

Trial

Phase 3, CARTITUDE-6

Conference

EBMT 2023

14 June, 2023 20:23

DETERMINATION: Does one size fit all in multiple myeloma?

Presented By

Dr Hani Hassoun, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, DETERMINATION

Conference

EBMT 2023

14 June, 2023 20:14

Graft-Versus-Host Disease

New options to treat steroid-refractory chronic GvHD

Presented By

Prof. Mohamad Mohty, Sorbonne University, France

Conference

EBMT 2023

15 June, 2023 16:59

New developments in steroid-refractory acute GvHD

Presented By

Prof. Ronjon Chakraverty, University of Oxford, UK

Conference

EBMT 2023

15 June, 2023 16:54

Miscellaneous Topics

Long-term success for CD19 CAR T-cell therapy in CLL

Presented By

Dr Emily Liang, University of Washington, WA, USA

Trial

Phase 2

Conference

EBMT 2023

15 June, 2023 17:31

Can molecular data improve prognostication in MDS patients undergoing HSCT?

Presented By

Dr Carmelo Gurnari, Cleveland Clinic, OH, USA & Tor Vergata University, Italy

Conference

EMBT 2023

15 June, 2023 17:27

Next-generation cell therapies for cancer: CAR-NK cells

Presented By

Dr Katy Rezvani, MD Anderson Cancer Center, TX, USA

Conference

EBMT 2023

15 June, 2023 17:20

Novel drugs and strategies around ASCT for Hodgkin lymphoma

Presented By

Dr Anna Sureda, Catalan Institute of Oncology, Spain

Conference

EBMT 2023

15 June, 2023 17:15

Thalassaemia: Advances in conventional transplantation and gene therapy

Presented By

Prof. Josu de la Fuente, Imperial College London, UK

Conference

EBMT 2023

15 June, 2023 17:06

Featured articles

CONTENTS

Online First

Acute Leukaemia

Multiple Myeloma

Graft-Versus-Host Disease

Miscellaneous Topics